BGaze Solutions are science-based tools that have been developed and validated in collaboration with leading clinicians.
In diagnostics, our tools add objectivity, save time, and improve interaction with the patient and his or her environment. BGaze ACE is a software-only, easy to adopt solution that streamlines the diagnostic process and uses AI technology to add objectivity to the interpretation of symptoms. It also includes a Posner task CPT. The BGaze Clinic system includes advanced eye-tracking hardware to capture involuntary biomarker micro eye movement patterns (patented worldwide) that provide an even higher degree of objective diagnostic accuracy.
In therapy, our solutions deliver a substantial measurable reduction of key issues such as inattention, impulsivity and others, which can minimize the need for pharmaceutical treatment.
Our center that always advocates the scientific advances that together with our experience makes us improve the quality of the life of patients, is proud to have been pioneers in using BGaze Clínic that more than one year ago we add to our team. With more than 300 children evaluated, we can say that BGaze provides objectivity to our clinical diagnostics. We believe it is a necessary tool and easy to use, as well as having a very operative technical department at all times.
We want to show Braingaze our gratitude for their research in the field of Mental Health, which allows us as clinical professionals to be more confident in diagnosing ADHD. Since last year, we use the BGaze Clinic system to support our ADHD and Dyslexia diagnoses. During this year we have seen the involvement of the professionals from Braingaze to complete a diagnostic platform based on a biomarker and the application of Artificial Intelligence. This platform facilitates our work and we encourage them to continue on other disorders such as Autism. They do a great job!
As a Mental Health clinic, we appreciate the effort of research companies such as Braingaze. Since they contacted us about the discovery of a neurobiological marker at the University of Barcelona two years ago, which is a tool for more objectively diagnose ADHD in children as well as in adults, and after a trial period to resolve our doubts, we implemented the BGaze platform in our clinic. At present we are very pleased to be part of the centers that use the system and with the benefits that the BGaze platform offers.
As an ADHD association, with our own team of professionals, we strive to be at the forefront of novel technologies and scientific advances, both in ADHD treatment and diagnosis, which is a complex process. For that reason we learned a year ago about the diagnostic platform BGaze Clinic, which is based on a biological neuromarker. Thus providing objectivity! After several conversations with opinion leaders and overcoming common resistance to change, we decided to use it in our clinical protocol. We are absolutely satisfied with the results.
We are a clinical center specialized in the research of cognitive disorders. Our ambition is to offer diagnosis and treatment of mental disorders from a new perspective and to offer maximum objectivity. We therefore integrated the BGaze Clinic platform as it provides us with everything we need to successfully diagnose our patients in a short time. This allows us to be more confident and start treatment and therapy right away. Thank you Braingaze!
BGaze Solutions are the result of over 5 years of research & development by University of Barcelona spin-off company Braingaze. The Braingaze development team is led by Prof Dr Hans Supèr, a highly recognized neurobiologist with over 20 years of solid experience in investigating the hard neurobiological aspects of cognition and attention and their disorders. The Braingaze team collaborates closely with leading psychiatrists such as Prof Dr Antoni Ramos-Quiroga (Head of the Department of Psychiatry at the Vall d'Hebron University Hospital, Spain), Dr José Alda (ADHD lead of the St Joan de Deu Specialized Pediatric Hospital in Spain) and renowned clinical psychologists like Dr Susan Young (Psychology Services Limited, UK).
Co-founder and CTO of Braingaze
Mental healthcare still mostly works with tools that reflect the technological capabilities of the previous millennium. This is unacceptable, given the huge impact that mental health has on the overall wellbeing of millions of persons and the huge impact that mental health has on the budgets for healthcare in developed countries. BGaze solutions bring mental healthcare into the digital, AI-empowered age leveraging patented and novel methods and combining those with practice-inspired protocols.